WO 2010/028432 titled ~ Protocols for Treating Bone Disorders -...

WO 2010/028432 titled ~ Protocols for Treating Bone Disorders - was published at the WIPO patent site tonight
I have also included the previous three publications for interest sake.


(WO 2010/028432)
PROTOCOLS FOR TREATING BONE DISORDERS
18.03.2010
HEALTHLINX LIMITED
The present invention relates generally to the field of bone disorders and in particular to the control of osteoporosis and related conditions including bone resorption and complications arising therefrom.

--------------------------------------------------------------------------------

(WO 2009/155637)
PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM
HEALTHLINX LIMITED
The present invention relates generally to the field of obesity and complications arising therefrom and in particular to the control of obesity by inhibiting adipogenesis and related processes.

--------------------------------------------------------------------------------

(WO 2009/129569)
AN ASSAY TO DETECT A GYNECOLOGICAL CONDITION
29.10.2009
HEALTHLINX LIMITED
The present invention relates generally to the field of diagnostic and prognostic assays for a gynecological condition. More particularly, the present invention provides an assay for diagnosing the presence of or a risk of having a gynecological cancer or a sub-type thereof or a stage of the cancer or complications arising therefrom or other gynecological condition including an inflammatory disorder.

--------------------------------------------------------------------------------

(WO 2008/058325)
IMMUNOAFFINITY COMPOSITIONS FOR IMMUNODEPLETION OF PROTEINS
22.05.2008
HEALTHLINX LIMITED
The present invention relates generally to the use of affinity compositions to clarify or modify a sample with respect to its complex constituency. More particularly, the present invention enables the treatment of a heterogeneous, complex sample to enrich the sample for particular molecules or groups of molecules. The clarified or modified samples of the present invention are useful inter alia in proteomic studies, diagnostics and in detection of selected low abundance, prognostic biomarkers and in therapeutic agent discovery regimes. The affinity compositions also have use for industrial applications. Affinity compositions are useful, therefore, in the removal of selected molecules from a sample. Affinity compositions in the form of